98 related articles for article (PubMed ID: 32087594)
21. D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Kanda Y; Kimura SI; Iino M; Fukuda T; Sakaida E; Oyake T; Yamaguchi H; Fujiwara SI; Jo Y; Okamoto A; Fujita H; Takamatsu Y; Saburi Y; Matsumura I; Yamanouchi J; Shiratori S; Gotoh M; Nakamura S; Tamura K;
J Clin Oncol; 2020 Mar; 38(8):815-822. PubMed ID: 31977270
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
[TBL] [Abstract][Full Text] [Related]
23. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia.
Liu X; Wang DF; Fang Y; Ye WF; Liu S; Lou N
Leuk Lymphoma; 2015 Jan; 56(1):85-91. PubMed ID: 24707944
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia.
Gatt ME; Strahilevitz J; Sharon N; Lavie D; Goldschmidt N; Kalish Y; Gural A; Paltiel OB
Integr Cancer Ther; 2015 Sep; 14(5):428-35. PubMed ID: 26036623
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients.
Intke C; Korpelainen S; Hämäläinen S; Vänskä M; Koivula I; Jantunen E; Pulkki K; Juutilainen A
Eur J Haematol; 2018 Aug; ():. PubMed ID: 30099772
[TBL] [Abstract][Full Text] [Related]
26. Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database.
Issa DE; Gelderblom H; Lugtenburg PJ; van Herk-Sukel MP; Houweling LM; De La Orden M; van der Werf-Langenberg ME; Nortier JW; de Jong FA
Eur J Cancer Care (Engl); 2015 Mar; 24(2):232-41. PubMed ID: 24528512
[TBL] [Abstract][Full Text] [Related]
27. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
28. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
Netterberg I; Karlsson MO; Nielsen EI; Quartino AL; Lindman H; Friberg LE
Br J Clin Pharmacol; 2018 Mar; 84(3):490-500. PubMed ID: 29178353
[TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.
Yokoyama M; Kusano Y; Takahashi A; Inoue N; Ueda K; Nishimura N; Mishima Y; Terui Y; Nukada T; Nomura T; Hatake K
Support Care Cancer; 2017 Nov; 25(11):3313-3320. PubMed ID: 28551843
[TBL] [Abstract][Full Text] [Related]
30. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
[TBL] [Abstract][Full Text] [Related]
31. Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
Wang L; Barron R; Baser O; Langeberg WJ; Dale DC
Value Health; 2014 Sep; 17(6):739-43. PubMed ID: 25236998
[TBL] [Abstract][Full Text] [Related]
32. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy.
Nakagawa Y; Suzuki K; Masaoka T
J Infect Chemother; 2009 Jun; 15(3):174-9. PubMed ID: 19554402
[TBL] [Abstract][Full Text] [Related]
34. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay JY; Chauvin F; Le Cesne A; Anglaret B; Bouhour D; Lasset C; Freyer G; Philip T; Biron P
J Clin Oncol; 1996 Feb; 14(2):636-43. PubMed ID: 8636781
[TBL] [Abstract][Full Text] [Related]
35. Incidence, Risk Factors, and Outcomes of Febrile Neutropenia in Thai Hematologic Malignancy Patients Receiving Chemotherapy: A 6-year Retrospective Cohort Study.
Limvorapitak W; Khawcharoenporn T
Asian Pac J Cancer Prev; 2015; 16(14):5945-50. PubMed ID: 26320477
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
Whited L; Grove M; Rose D; Rhodes NJ; Scheetz MH; O'Donnell JN; Neeb J; Thoele K; Jones DR; Lowe C; Moore D; Kiel PJ
Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
[TBL] [Abstract][Full Text] [Related]
38. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Sutheesophon J; Sutcharitchan P; Swasdikul D
Leuk Lymphoma; 2000 Apr; 37(3-4):351-60. PubMed ID: 10752986
[TBL] [Abstract][Full Text] [Related]
39. Measurements of procalcitonin facilitate targeting of endotoxin adsorption treatment in febrile neutropenic patients suffering from shock.
Hara M; Tsuchiya K; Nitta K; Ando M
Clin Nephrol; 2014 Jan; 81(1):67-70. PubMed ID: 22909782
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with Survival Outcomes of Febrile Neutropenia in Hematologic Malignancy Patients.
Weerasubpong B; Makruasi N; Linasmita P; Rattanamongkolgul S
J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S53-S62. PubMed ID: 29901912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
